132 related articles for article (PubMed ID: 37773852)
1. Association of radiotherapy with thoracic vertebral fractures in esophageal squamous cell carcinoma: A retrospective cohort study.
Wu XQ; Zhang TY; Yang F; Feng XY; Feng YL; Wang LL; Chen TW; Li CP; Li R
Medicine (Baltimore); 2023 Sep; 102(39):e35304. PubMed ID: 37773852
[TBL] [Abstract][Full Text] [Related]
2. Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer.
Fujii K; Sakanaka K; Uozumi R; Ishida Y; Inoo H; Tsunoda S; Miyamoto S; Muto M; Mizowaki T
JAMA Netw Open; 2020 Sep; 3(9):e2013952. PubMed ID: 32870311
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
4. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density loss in thoracic and lumbar vertebrae following radiation for abdominal cancers.
Wei RL; Jung BC; Manzano W; Sehgal V; Klempner SJ; Lee SP; Ramsinghani NS; Lall C
Radiother Oncol; 2016 Mar; 118(3):430-6. PubMed ID: 26993414
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
7. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
8. Caution against simultaneous integrated boost radiotherapy for upper thoracic esophageal squamous cell carcinoma: results from a single-arm phase II trial.
Zhou Y; Chu L; Lu S; Chu X; Ni J; Li Y; Guo T; Yang X; Zhu Z
Esophagus; 2023 Oct; 20(4):713-721. PubMed ID: 37149827
[TBL] [Abstract][Full Text] [Related]
9. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
10. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
13. Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.
Guan H; Yu Y; Ge H; Zhu S; Huang W; Li B
Future Oncol; 2019 Oct; 15(29):3345-3355. PubMed ID: 31578872
[No Abstract] [Full Text] [Related]
14. Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective.
Kim KH; Chang JS; Cha JH; Lee IJ; Kim DJ; Cho BC; Park KR; Lee CG
Cancer Res Treat; 2017 Jan; 49(1):168-177. PubMed ID: 27338033
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
16. Risk Factors for Refracture following Primary Osteoporotic Vertebral Compression Fractures.
Ji C; Rong Y; Wang J; Yu S; Yin G; Fan J; Tang P; Jiang D; Liu W; Gong F; Ge X; Cai W
Pain Physician; 2021 May; 24(3):E335-E340. PubMed ID: 33988955
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma.
Sasaki K; Uchikado Y; Omoto I; Arigami T; Osako Y; Noda M; Okumura H; Maemura K; Higashi R; Yoshiura T; Natsugoe S
Cancer Chemother Pharmacol; 2019 Mar; 83(3):581-587. PubMed ID: 30623230
[TBL] [Abstract][Full Text] [Related]
18. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of predictive factors of vertebral compression fracture after conventional palliative radiotherapy for spinal metastasis from colorectal cancer.
Lee J; Rhee WJ; Chang JS; Chang SK; Koom WS
J Neurosurg Spine; 2018 Mar; 28(3):333-340. PubMed ID: 29271724
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
